NL-OMON21465
Completed
Phase 4
Prospective monitoring of immune response following COVID-19 vaccination in children with cancer
Princess Máxima Center for Pediatric Oncology0 sites130 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- <tr><td>Childhood cancer, Corona vaccination, immune response</td></tr>
- Sponsor
- Princess Máxima Center for Pediatric Oncology
- Enrollment
- 130
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
Will follow
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Bereid gevaccineerd te worden met een routine Pfizer of Moderna vaccin, als onderdeel van het nationalevaccinatieprogramma (cohort I) |
Exclusion Criteria
- •\- Voorgeschiedenis van ernstige ongewenste reacties, geassocieerd met een vaccin en/of ernstige allergischereactie (bijv. anafylactisch) op een grondstof van het vaccin |
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Monitoring response on COVID-19 vaccination in children with cancerChildren with cancer, receiving COVID-19 vaccinationTherapeutic area: Body processes [G] - Immune system processes [G12]EUCTR2021-003388-90-NLPrincess Máxima Center for Pediatric Oncology130
Completed
Phase 4
Prospective monitoring of immune response following COVID-19 vaccination in children with cancerNL-OMON52106Prinses Máxima Centrum voor Kinderoncologie130
Active, not recruiting
Phase 1
Effectivity of COVID-19 vaccination in people with Down syndromeEUCTR2021-002613-34-NLniversity Medical Center Utrecht640
Recruiting
Phase 4
Prospective monitoring of antibody response following COVID-19 vaccination in patients with Down syndromeNL-OMON54387niversitair Medisch Centrum Utrecht640
Suspended
Not Applicable
Establishment of an immune monitoring for the prevention ofrejection and infections after kidney transplantatioZ94.0Kidney transplant statusDRKS00032849ierenzentrum Heidelberg500